Everbright Securities Co Ltd (601788)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 13.45 |
|---|---|
| 52-week range | 13.06 – 19.25 |
| Return, 1 month / 3 months | −3.7% / −8.8% |
| Return, 1 year / 3 years | −27.6% / −11.6% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 20.8% |
| Worst drawdown (1 year) | -29.5% |
| Average daily value traded | 245.17M CNY |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Everbright Securities is a Chinese financial services firm based in Shanghai. It offers securities brokerage to individual and institutional investors, along with investment banking services such as underwriting and corporate finance advice, and asset management through funds and wealth products. Its customers include retail investors, companies seeking capital markets services, and institutions, and it operates mainly in mainland China through a network of branches and subsidiaries.
Everbright Securities Co Ltd trades under the code 601788 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Everbright Securities Co Ltd (601788) trades on the Shanghai Stock Exchange in China. It last closed at CNY 13.45 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 467 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 27.6% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.0% | ||
| From 52-week high | -30.0% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.8% | ||
| 6-month return | -8.8% | ||
| 12-month return, skipping the last month | -24.9% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.5% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 245.17M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −3.7% |
| 3 months | −8.8% |
| 6 months | −8.8% |
| 1 year | −27.6% |
| 3 years | −11.6% |
| 5 years | −9.5% |
Signals
| 50-day / 200-day average | 14.08 / 15.11 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.23 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | CNY 0.1740 |
| 26 Nov 2025 | CNY 0.1095 |
| 13 Aug 2025 | CNY 0.1086 |
| 10 Dec 2024 | CNY 0.0905 |
| 25 Jul 2024 | CNY 0.2803 |
| 22 Aug 2023 | CNY 0.2100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.